Barry Buffman
Urology · Quartz Hill, CANPI 1356480016
Payments from drug & device makers
Across 204 payments — averaging $662.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$106K
- Novo Nordisk AS$25K
- Novo Nordisk$646
- Irhythm Technologies, Inc.$336
- Boehringer Ingelheim$308
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$262
- plus $2K from 32 others
What the payments were for
- Food & beverage$5,064100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 38 | $106,102 |
| Novo Nordisk AS | 29 | $25,473 |
| Novo Nordisk | 31 | $646 |
| Irhythm Technologies, Inc. | 20 | $336 |
| Boehringer Ingelheim | 10 | $308 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $262 |
| GSK | 8 | $236 |
| Lilly USA, LLC | 6 | $225 |
| Bayer | 6 | $205 |
| Merck | 5 | $181 |
| Amgen | 4 | $178 |
| Pfizer | 8 | $174 |
| Gilead | 1 | $125 |
| Dexcom, Inc. | 4 | $124 |
| AbbVie | 1 | $123 |
| Stryker | 2 | $71 |
| Vision Quest Industries Inc. | 3 | $41 |
| Eisai Inc. | 2 | $36 |
| Novartis | 2 | $33 |
| Biohaven Pharmaceuticals, Inc. | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Corcept Therapeutics | 1 | $27 |
| Vertiflex, Inc. | 1 | $25 |
| Philips North America LLC | 1 | $24 |
| Exact Sciences | 1 | $24 |
| Endo Pharmaceuticals Inc. | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| Grifols USA, LLC | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Smith+Nephew | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Zyla Life Sciences, Inc. | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
| Xeris Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$135,246 in reported general payments places this provider in the 90th percentile of 1,324 urology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 54 | $79,570 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 88 | $54,797 |
| EliquisApixaban | 21 | $30,771 |
| JanuviaSitagliptin Phosphate | 24 | $22,746 |
| JardianceEmpagliflozin | 15 | $19,516 |
| OzempicSemaglutide | 11 | $10,405 |
| JanumetSitagliptin Phos/Metformin Hcl | 15 | $7,494 |
| AirsupraAlbuterol Sulfate/Budesonide | 13 | $6,548 |
| Icosapent Ethyl | 18 | $4,670 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $4,227 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 24 | $3,633 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 114 | $3,372 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 159 | $2,574 |
| Atorvastatin Calcium | 196 | $1,936 |
| Testosterone Cypionate | 32 | $1,611 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $646 | $89,97565 claims |
| GSKTrelegy Ellipta | $236 | $54,79788 claims |
| PfizerEliquis | $174 | $30,77121 claims |
| MerckJanuvia, Janumet | $181 | $30,24039 claims |
| Boehringer IngelheimJardiance | $308 | $19,51615 claims |
| AstraZenecaAirsupra | $106,102 | $6,54813 claims |
| AbbVieSynthroid | $123 | $68018 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,324 urology providers in California.
Other urology in Quartz Hill
- Edward UchioOrange$21.1M
- Stephen FreedlandWest Hollywood$16.7M
- Alec KooTorrance$7.4M
- Karim ChamieLos Angeles$4.3M
- Ralph ClaymanOrange$3.9M
- Siamak DaneshmandLos Angeles$3.5M
- Arnold ChinLos Angeles$3.5M
- Roger LiLoma Linda$2.3M
- John KowalczykLos Angeles$1.8M
- Arie BelldegrunLos Angeles$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.